Work

A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation

Year: 2012

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mds523

Authors: T.Y. Seiwert, T. Darga, D. Haraf, E.A. Blair, K. Stenson, E.E.W. Cohen, J.K. Salama, V. Villaflor, M.E. Witt, M.W. Lingen, R.R. Weichselbaum, E.E. Vokes

Institution: University of Chicago

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Cancer Institute

Awards: DNA Damage Targeted Gene Therapy in Head & Neck Cancer, G4173054129

OpenAlex ID: W2125295227

FWCI: 1.156

Cites: 48

Cited by: 29

Related to: 10